The care of NSCLC (NSCLC) has been revolutionized by Tagrisso, which is also known as Tagrisso, a precision cancer drug.Tagrisso, a medication from the class of TKIs (TKIs), has been endorsed by the U.S. Food and Drug Administration (Food and Drug Administration), and is recommended for the care of progressive NSCLC.This article aims to explore various aspects of Tagrisso, which includes its working principle, indications, adverse effects, and the importance of the EMA (EMA) in the drug's regulatory approval.By occluding the function of the EGFR (EGFR) tyrosine kinase, which is…
